Use-result survey of FluMist intranasal spray

JRCT ID: jRCT2031240117

Registered date:27/05/2024

Basic Information

• Recruitment status: Pending
• Health condition(s) or Problem(s) studied: Influenza virus infection
• Date of first enrollment: 01/09/2024
• Target sample size: 3000
• Study type: Observational

Outcome(s)

• Primary Outcome: Safety Specifications and factors affecting safety in this study

Key inclusion & exclusion criteria

• Age minimum: >= 2age old
• Age maximum: < 19age old
• Gender: Both

Include criteria

Subjects who fulfilled the following criteria at the time of registration
1) Subjects who are receiving FluMist intranasal spray for the first time to prevent Influenza virus infection
2) Subjects giving written consent from the study subjects or their guardians.
3) Subjects who are received FluMist intranasal spray during the contract period (contract period based on the contract with each medical site)
4) Subjects who are received FluMist intranasal spray during the registration period
5) Subjects who are 2 years old over and younger than 19 years old at the time of vaccination

• Exclude criteria: none

Related Information

• Primary Sponsor: Tanabe for Hirokazu